who reported this tumor‐promoting feel‐forward pathway between miR‐145 and RAS in RAS‐mutant pancreatic cancer, and the downregulation of miR‐145 required the RAS‐responsive element‐binding protein (RREB1), which repressed the miR‐145 promoter 40. Here, RREB1 is linked to neoplasm.